The counterfeit drug trade has changed over the last decade. Prominent Leaders in the pharma industry all agree, counterfeiters have become more sophisticated. This has presented challenges to manufacturers to protect the brand security and safety of their products.
As Pat Ford, Pfizer's Senior Director for Global Security, said the situation is "like the Wild West," which poses a particular problem for those dispensing the drugs. "It gets to the point that pharmacists can't tell the difference. That's why we educate them on features in the packaging that help distinguish the real from the fake. And it's not just an international problem, but one unfolding right here in the United States.
As Pat Ford, Pfizer's Senior Director for Global Security, said the situation is "like the Wild West," which poses a particular problem for those dispensing the drugs. "It gets to the point that pharmacists can't tell the difference. That's why we educate them on features in the packaging that help distinguish the real from the fake. And it's not just an international problem, but one unfolding right here in the United States.
Posts
No comments:
Post a Comment